PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33629212-0	2021	Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma.	ibrutinib	55-64	BCL6 transcription repressor	Homo sapiens	15-19	
33629212-10	2021	In addition, another expression profile from GEO database showed that BCL6 was significantly high expression in no responsive patients after Ibrutinib treatment, and the receiver operating characteristic (ROC) curve which was used to evaluate the relationship between BCL6 expression and its effect was 0.67.	ibrutinib	141-150	BCL6 transcription repressor	Homo sapiens	70-74	
33629212-11	2021	MTT assay showed that treatment with FX1 (a BCL6 inhibitor) can enhance the sensitivity of Ibrutinib in C481S BTK HBL-1 cells.	ibrutinib	91-100	BCL6 transcription repressor	Homo sapiens	44-48	
33629212-12	2021	The results suggested that BCL6 and miR-30 family maybe associate with Ibrutinib resistance in ABC-DLBCL.	ibrutinib	71-80	BCL6 transcription repressor	Homo sapiens	27-31